Cross-Disciplinary Approaches to Understanding Neurodegenerative Diseases: Insights from Molecular Biology and Biochemistry

Authors

  • Mahatma Gandhi Coastal Dynamics Unit, Australia Author

Keywords:

Neurodegenerative diseases, molecular biology, biochemistry, protein misfolding, oxidative stress, mitochondrial dysfunction, biomarkers, therapeutic targets, genetic predispositions, environmental factors, translational research, integrative models

Abstract

Neurodegenerative diseases (NDs) such as Alzheimer’s, Parkinson’s, and Huntington’s disease are characterized by progressive neuronal loss, leading to significant cognitive and motor dysfunction. Understanding the underlying mechanisms of these diseases necessitates a cross-disciplinary approach, integrating insights from molecular biology and biochemistry. This review synthesizes current research emphasizing the molecular pathways implicated in neurodegeneration, including protein misfolding, oxidative stress, and mitochondrial dysfunction. Key molecular players, such as amyloid-beta, tau, alpha-synuclein, and huntingtin, are examined for their roles in pathogenesis and neurotoxicity. Recent advancements in biochemical techniques, including mass spectrometry and high-throughput screening, have unveiled potential biomarkers and therapeutic targets, highlighting the importance of translational research in developing effective treatments. Moreover, the interaction between genetic predispositions and environmental factors is explored to elucidate their contributions to disease onset and progression. By fostering collaboration between molecular biologists, biochemists, and neuroscientists, this review aims to enhance the understanding of NDs and encourage innovative strategies for intervention. Future directions emphasize the need for integrative models that combine experimental and computational approaches, thereby offering a holistic view of neurodegeneration. Ultimately, a robust understanding of the molecular and biochemical underpinnings of neurodegenerative diseases can pave the way for novel therapeutic avenues, enhancing patient outcomes and quality of life.

Downloads

Published

2024-10-10